NRx Pharmaceuticals, HOPE Therapeutics announces Cohen & Associates inclusion

HOPE Therapeutics, an interventional psychiatry network owned by NRx Pharmaceuticals (NRXP), announced the acquisition of a strategic interest in Cohen and Associates, and its incorporation into the HOPE Network. Additionally, Rebecca Cohen, MD has joined HOPE as Medical Director, overseeing medical standards of care throughout HOPE’s Florida locations. Cohen, LLC is one of the premier interventional Psychiatry clinics in the region. The clinic offers a full range of treatments for suicidal depression, PTSD and other CNS disorders, including ketamine, Transcranial Magnetic Stimulation, and medication management. Dr. Cohen is an Interventional Psychiatrist and Psychopharmacologist specializing in the treatment of mood and anxiety disorders as well as a nationally recognized expert in TMS.